Induction of “In Vitro” Apoptosis by Fludarabine in Freshly Isolated B-Chronic Lymphocytic Leukemia Cells
- 1 January 1994
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 13 (1-2) , 95-97
- https://doi.org/10.3109/10428199409051657
Abstract
The cytotoxic effects and apoptosis (programmed cell death) induced by fludarabine (FLU), interleukin-2 (IL-2), interleukin-4 (IL-4), IL-2 plus IL-4, α-interferon (a-IFN), and mafos-famide were evaluated “in vitro” on freshly isolated B-cell chronic lymphocytic leukemia (B-CLL) cells. Cytotoxicity was evaluated according to the soluble tetrazolium/formazan assay. Treatment with mafosfamide, fludarabine, and IL-4 resulted in significant anti-tumor activity against all the freshly isolated samples. On the other hand, no significant cytotoxic activity was observed with α-IFN, IL-2, and the combination of IL-2 and IL-4. Apoptosis was evaluated by electrophoresis gel of DNA oligonucleosomal fragments and only FLU significantly activated apoptosis in all the samples. It appears that fludarabine is active against B-CLL cells acting by an direct cytotoxic effect and/or the induction of cell death by apoptosis.Keywords
This publication has 5 references indexed in Scilit:
- Treatment of advanced chronic lymphocytic leukemia by fludarabineAnnals of Hematology, 1991
- Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.Journal of Clinical Oncology, 1991
- Fludarabine: a new agent with major activity against chronic lymphocytic leukemiaBlood, 1989
- Biologic activity of 9-β-d-arabinofuranosyl-2-fluoroadenine, a metabolically stable analog of 9-β-d-arabinofuranosyladenineBiochemical Pharmacology, 1977
- Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue KineticsBritish Journal of Cancer, 1972